Molecular Diagnostics Market Size & Share Growth, Trends 2028

    Molecular Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Disease Area (Oncology, Infectious diseases, Genetic testing, Cardiac diseases, Immune system disorders, and Others); Technology (Polymerase Chain Reaction (PCR), Isothermal Nucleic Acid Amplification Technology (INAAT), DNA Sequencing and Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others); Product and Services (Assays and Kits, Instruments, Services and Software); End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others) and Geography

    Publication Month: Nov 2021 | Report Code: TIPRE00003124 | No. of Pages: 253 | Category: Medical Device | Status: Published

    The molecular diagnostics market is projected to grow from US$ 16,258.97 million in 2021 to US$ 36,176.65 million by 2028; it is expected to grow at a CAGR of 12.1% during 2021-2028.

    Point-of-care (POC) is one emerging healthcare service, which is being aggressively adopted by patients and healthcare service providers alike. It is extensively used in various healthcare processes, such as treatment, diagnostics, and patient monitoring. Leading medical device manufacturers and players in associated markets are actively involved in product innovation and development processes.

    A few examples are mentioned below:

    • In July 2021, Abbott launched its Panbio COVID-19 rapid antigen tests in India.
    • In July 2021, Siemens Healthineers began manufacturing its molecular diagnostic kits, including the COVID-19 testing - IMDX SARS-CoV2 in its Vadodara, India facility.
    • In September 2021, Chembio Diagnostics, Inc. initiated the Emergency Use Authorization (EUA) application to the Food and Drug Administration (FDA) for the company's DPP Respiratory Antigen Panel Test System. It is designed to allow simultaneous, discrete, and differential detection of viral infections such as influenza A, influenza B, and SARS-CoV-2 antigens from a single patient's nasal swab sample.

    Moreover, patients prefer at-home medical care through POC products and services due to increasing awareness about POC products and services. It reduces patient movement, risk of infection, and facility cost for healthcare service providers. These factors are boosting the growth of the global molecular diagnostics market

    Strategic Insights

    Lucrative Regions in Molecular Diagnostics Market

    Lucrative Regions in Molecular Diagnostics Market

    Get more information on this report :


    Market Insights
    Increasing Prevalence of Associated Diseases Drives Molecular Diagnostics Market

    Molecular diagnostics has wide application in various indications such as Oncology, Infectious disease, Genetic testing, Cardiac diseases, Immune system disorders, Others. The increasing prevalence of the associated indications is expected to drive the market. For instance, cancer is one of the leading causes of death worldwide. The early detection of cancer can prevent death among the patients. POC diagnostics play an essential role in the early role and monitoring of cancer. The World Health Organization (WHO) stated that about 70% of deaths in low- and middle-income countries were caused by cancer in September 2021. In addition, as per the Global Burden of Disease Study in the Global Health Data Exchange and the World Health Statistics 2020 Cardiovascular Disease (CVD) mortality in China 322 per 100,000 population, India has reported 185 per 100,000 population of an early stage of CVD.

    Moreover, as per the American Cancer Society in the US it is estimated that about 1.9 million new cancer cases diagnosed in the year 2021. Moreover, as per the data published by the UK.GOV in 22nd of November 2021 infection rate of COVID19 is about 422.7 per 100,000 population. Thus, the rising prevalence of target diseases in molecular diagnostics is expected to drive the market. During the forecast period.

    Technology-Based Insights

    The Molecular Diagnostics market, by technology, is bifurcated into [Polymerase Chain Reaction (PCR), isothermal nucleic acid amplification technology, DNA Sequencing and Next-Generation Sequencing (NGS), In Situ Hybridization, DNA Microarray, and Others. The in-vitro segment led the market in 2021, contributing to a market share of 64.45%, and is expected to retain its dominance during the forecast period to account for a market share of 65.73% of the overall revenue generated in 2028.

    Molecular Diagnostics Market, by technology – 2021 and 2028

    Molecular Diagnostics Market, by technology – 2021 and 2028

    Get more information on this report :



    Disease Area-Based Insights

    By disease area, the molecular diagnostics market is bifurcated into oncology, infectious diseases, genetic testing, cardiac diseases, immune system disorders, and others. In 2021, the infectious disease segment held a larger share of the market. Moreover, the market for the oncology segment is expected to grow at a faster CAGR of 12.5% during 2021–2028.

    Product and Services -Based Insights

    The molecular diagnostics market, by assays and kits, instruments, services and software. In 2021, the assays and kits segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 3.5% during 2021–2028.

    End-User-Based Insights

    The molecular diagnostics market, based on end user, is segmented into hospitals and clinics, diagnostic laboratories, research and academic institutes, and others. In 2021, the diagnostic laboratories segment held the largest share of the market. Moreover, the market for the same segment is expected to grow at the fastest CAGR of 12.5% during 2021–2028.

    Product launches and approvals are commonly adopted strategies by companies to expand their global footprints and product portfolios. Moreover, the molecular diagnostics market players focus on the partnership strategy to enlarge their clientele, which, in turn, permits them to maintain their brand name across the world.

    The report segments Global Molecular Diagnostics market as follows

    By Disease Area

    • Infectious Disease
    • Oncology
    • Genetic Testing
    • Cardiac Diseases
    • Immune System Disorders
    • Others

    By Technology

    • Polymerase Chain Reaction (PCR)
      • RT-PCR
      • qPCR
      • Multiplex PCR
      • Others
    • In Situ Hybridization
    • Isothermal Nucleic Acid Amplification Technology (INAAT)
    • DNA Sequencing and Next-Generation Sequencing (NGS)
    • DNA Microarrays
    • Others

    By Product and Services

    • Assays and Kits
    • Instruments
    • Services and Software

    By End User

    • Diagnostic Laboratories
    • Hospitals and Clinics
    • Research and Academic Institutes
    • Others

    By Geography

    • North America
      • US
      • Canada
      • Mexico
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Malaysia
      • Thailand
      • Singapore
      • Philippines
      • Vietnam
      • Indonesia
      • Rest of Asia Pacific
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • South Africa
      • Rest of Middle East & Africa
    • South and Central America
      • Brazil
      • Argentina
      • Rest of South and Central America

    Company Profiles

    • Abbott
    • Agilent Technologies, Inc.
    • Thermo Fisher Scientific Inc.
    • F. Hoffmann-La Roche Ltd.
    • TBG Diagnostics Limited
    • QIAGEN
    • bioMérieux SA
    • Siemens Healthineers AG
    • Illumina, Inc.
    • Danaher
    • Novartis AG

    1. Introduction

    1.1 Scope of the Study

    1.2 The Insight Partners Research Report Guidance

    1.3 Market Segmentation

    1.3.1 Global Molecular Diagnostics Market – By Disease Area

    1.3.2 Global Molecular Diagnostics Market – By Technology

    1.3.3 Global Molecular Diagnostics Market – By Product and Services

    1.3.4 Global Molecular Diagnostics Market – By End User

    1.3.5 Global Molecular Diagnostics Market – By Geography

    2. Key Takeaways

    3. Research Methodology

    3.1 Coverage

    3.2 Secondary Research

    3.3 Primary Research

    4. Molecular Diagnostics Market – Market Landscape

    4.1 Overview

    4.2 PEST Analysis

    4.2.1 North America PEST Analysis

    4.2.2 Europe PEST Analysis

    4.2.3 Asia Pacific PEST Analysis

    4.2.4 Middle East and Africa PEST Analysis

    4.2.5 South and Central America PEST Analysis

    4.3 Experts Opinion

    5. Molecular Diagnostics Market – Key Market Dynamics

    5.1 Market Drivers

    5.1.1 Increase in Demand for Point-of-Care and Developments by Market Players

    5.1.2 Increasing Prevalence of Associated Diseases

    5.2 Market Restraints

    5.2.1 Limitations Associated the Molecular Testing

    5.3 Market Opportunities

    5.3.1 Global and Regional Players to Explore Untapped Markets for Potential Opportunities

    5.4 Future Trends

    5.4.1 Increasing Popularity of At-home Healthcare Services

    5.5 Impact Analysis

    6. Molecular Diagnostics Market– Global Analysis

    6.1 Global Molecular Diagnostics Market Revenue Forecast and Analysis

    6.2 Global Molecular Diagnostics Market, By Geography - Forecast and Analysis

    6.3 Market Share of Key Players (%), 2020

    7. Molecular Diagnostics Market Analysis – By Disease Area

    7.1 Overview

    7.2 Molecular Diagnostics Market Revenue Share, by Disease Area (2021 and 2028)

    7.3 Oncology

    7.3.1 Overview

    7.3.2 Oncology: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.4 Infectious Disease

    7.4.1 Overview

    7.4.2 Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.5 Genetic Testing

    7.5.1 Overview

    7.5.2 Genetic Testing: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.6 Cardiac Diseases

    7.6.1 Overview

    7.6.2 Cardiac Diseases: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.7 Immune System Disorders

    7.7.1 Overview

    7.7.2 Immune System Disorders: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    7.8 Others

    7.8.1 Overview

    7.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8. Molecular Diagnostics Market– By Technology

    8.1 Overview

    8.2 Molecular Diagnostics Market Revenue Share, by Technology (2021 and 2028)

    8.3 Polymerase Chain Reaction (PCR)

    8.3.1 Overview

    8.3.2 Polymerase Chain Reaction (PCR): Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.1 RT-PCR

    8.3.2.1.1 Overview

    8.3.2.1.2 RT-PCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.2 qPCR

    8.3.2.2.1 Overview

    8.3.2.2.2 qPCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.3 Multiplex PCR

    8.3.2.3.1 Overview

    8.3.2.3.2 Multiplex PCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.3.2.4 Others

    8.3.2.4.1 Overview

    8.3.2.4.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)

    8.4.1 Overview

    8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.5 DNA Sequencing and Next-Generation Sequencing (NGS)

    8.5.1 Overview

    8.5.2 DNA Sequencing and Next-Generation Sequencing: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.6 DNA Microarrays

    8.6.1 Overview

    8.6.2 DNA Microarrays: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.7 In-Situ Hybridization (ISH)

    8.7.1 Overview

    8.7.2 In-Situ Hybridization: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    8.8 Others

    8.8.1 Overview

    8.8.2 Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    9. Molecular Diagnostics Market– by Product and Services

    9.1 Overview

    9.2 Molecular Diagnostics Market, By Product and Services, 2021 & 2028 (%)

    9.3 Assays and Kits

    9.3.1 Overview

    9.3.2 Assays and Kits: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    9.4 Instruments

    9.4.1 Overview

    9.4.2 Instruments: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    9.5 Services and Software

    9.5.1 Overview

    9.5.2 Services and Software: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    10. Molecular Diagnostics Market Revenue and Forecasts To 2028 – End User

    10.1 Overview

    10.2 Molecular Diagnostics Market Share by End User - 2021 & 2028 (%)

    10.3 Hospitals and Clinics

    10.3.1 Overview

    10.3.2 Hospitals and Clinics: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    10.4 Diagnostic Laboratories

    10.4.1 Overview

    10.4.2 Diagnostic Laboratories: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    10.5 Research and Academic Institutes

    10.5.1 Overview

    10.5.2 Research and Academic Institutes: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    10.6 Others

    10.6.1 Overview

    10.6.2 Others: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    11. Molecular Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis

    11.1 North America: Molecular Diagnostics Market

    11.1.1 Overview

    11.1.2 North America: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.3 North America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.1.4 North America: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.1.4.1 North America: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.1.5 North America: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.1.6 North America: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.1.7 North America: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    11.1.7.1 US: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.1.1 Overview

    11.1.7.1.2 US: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.1.3 US: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.1.7.1.4 US: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.1.7.1.4.1 US: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.1.7.1.5 US: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.1.6 US: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.2 Canada: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.2.1 Overview

    11.1.7.2.2 Canada: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.2.3 Canada: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.1.7.2.4 Canada: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.1.7.2.4.1 Canada: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.1.7.2.5 Canada: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.2.6 Canada: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.3 Mexico: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.3.1 Overview

    11.1.7.3.2 Mexico: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.3.3 Mexico: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.1.7.3.4 Mexico: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.1.7.3.4.1 Mexico: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.1.7.3.5 Mexico: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.1.7.3.6 Mexico: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2 Europe: Molecular Diagnostics Market

    11.2.1 Overview

    11.2.2 Europe: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.3 Europe: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.4 Europe: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.4.1 Europe: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.5 Europe: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.6 Europe: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7 Europe: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    11.2.7.1 Germany: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.1.1 Overview

    11.2.7.1.2 Germany: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.1.3 Germany: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.7.1.4 Germany: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.7.1.4.1 Germany: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.1.5 Germany: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.1.6 Germany: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2 France: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2.1 Overview

    11.2.7.2.2 France: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2.3 France: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.7.2.4 France: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.7.2.4.1 France: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.2.5 France: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.2.6 France: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3 UK: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3.1 Overview

    11.2.7.3.2 UK: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3.3 UK: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.7.3.4 UK: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.7.3.4.1 UK: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.3.5 UK: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.3.6 UK: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4 Italy: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4.1 Overview

    11.2.7.4.2 Italy: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4.3 Italy: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.7.4.4 Italy: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.7.4.4.1 Italy: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.4.5 Italy: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.4.6 Italy: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5 Spain: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5.1 Overview

    11.2.7.5.2 Spain: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5.3 Spain: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.2.7.5.4 Spain: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.2.7.5.4.1 Spain: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.5.5 Spain: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.5.6 Spain: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6 Rest of Europe: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.1 Overview

    11.2.7.6.2 Rest of Europe: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.3 Rest of Europe: Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.4 Rest of Europe: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.2.7.6.4.1 Rest of Europe: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.2.7.6.5 Rest of Europe: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.2.7.6.5.1 Rest of Europe: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.3 Asia Pacific

    11.3.1 Overview

    11.3.2 Asia Pacific: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.3 Asia Pacific : Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.4 Asia Pacific : Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.4.1 Asia Pacific : Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

    11.3.5 Asia Pacific : Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.6 Asia Pacific : Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7 Molecular Diagnostics Market Revenue Share, by Country (2021 and 2028)

    11.3.7.1 India: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.1.1 Overview

    11.3.7.1.2 India: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.1.3 India: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.1.4 India: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.1.4.1 India: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.1.5 India: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.1.6 India: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.2 Singapore: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.2.1 Overview

    11.3.7.2.2 Singapore: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.2.3 Singapore: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.2.4 Singapore: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.2.4.1 Singapore: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.2.5 Singapore: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.2.6 Singapore: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.3 Philippines: Molecular Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.3.1 Overview

    11.3.7.3.2 Philippines: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.3.3 Philippines: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.3.4 Philippines: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.3.4.1 Philippines: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.3.5 Philippines: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.3.6 Philippines: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.4 Indonesia: Molecular Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.4.1 Overview

    11.3.7.4.2 Indonesia: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.4.3 Indonesia: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.4.4 Indonesia: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.4.4.1 Indonesia: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.4.5 Indonesia: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.4.6 Indonesia: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.5 Vietnam: Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.5.1 Overview

    11.3.7.5.2 Vietnam: Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.5.3 Vietnam: Molecular diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.5.4 Vietnam: Molecular diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.5.4.1 Vietnam: Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

    11.3.7.5.5 Vietnam: Molecular diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.5.6 Vietnam: Molecular diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.6 Thailand: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.6.1 Overview

    11.3.7.6.2 Thailand: Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.6.3 Thailand: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.6.4 Thailand: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.6.4.1 Thailand: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.6.5 Thailand: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.6.6 Thailand: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.7 Malaysia : Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.7.1 Overview

    11.3.7.7.2 Malaysia : Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.7.3 Malaysia : Molecular diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.7.4 Malaysia : Molecular diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.7.4.1 Malaysia : Polymerase Chain Reaction (PCR) Market, by Type, 2019–2028 (US$ Million)

    11.3.7.7.5 Malaysia : Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.7.6 Malaysia : Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.3.7.8 Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.8.1 Overview

    11.3.7.8.2 Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.8.3 Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.3.7.8.4 Japan: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.3.7.8.4.1 Japan: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.3.7.8.5 Japan: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.8.6 Japan: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.9 China: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.9.1 Overview

    11.3.7.9.2 China: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.9.3 China: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.3.7.9.4 China: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.3.7.9.4.1 China: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.3.7.9.5 China: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.9.6 China: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.10 South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.10.1 Overview

    11.3.7.10.2 South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.10.3 South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.3.7.10.4 South Korea: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.3.7.10.4.1 South Korea: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.3.7.10.5 South Korea: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.10.6 South Korea: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.11 Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.11.1 Overview

    11.3.7.11.2 Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.3.7.11.3 Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.3.7.11.4 Australia: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.3.7.11.4.1 Australia: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.3.7.11.5 Australia: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.11.6 Australia: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.12 Rest of Asia Pacific: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.12.1 Overview

    11.3.7.12.2 Rest of Asia Pacific: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    11.3.7.12.3 Rest of Asia Pacific: Molecular Diagnostics Market, by Disease Area, 2019–2028 (US$ Million)

    11.3.7.12.4 Rest of Asia Pacific: Molecular Diagnostics Market, by Technology, 2019–2028 (US$ Million)

    11.3.7.12.4.1 Rest of Asia Pacific: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.3.7.12.5 Rest of Asia Pacific: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.3.7.12.6 Rest of Asia Pacific: Molecular Diagnostics Market, by End User, 2019–2028 (US$ Million)

    11.4 Middle East & Africa Molecular Diagnostics Market Revenue and Forecasts To 2028

    11.4.1 Overview

    11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.3 Middle East & Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.4.4 Middle East & Africa: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.4.4.1 Middle East & Africa: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.4.5 Middle East & Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.4.6 Middle East & Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.4.7 Middle East & Africa: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    11.4.7.1 UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.1.1 Overview

    11.4.7.1.2 UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.1.3 UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.4.7.1.4 UAE: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.4.7.1.4.1 UAE: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.4.7.1.5 UAE: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.1.6 UAE: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.2 Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.2.1 Overview

    11.4.7.2.2 Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.2.3 Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.4.7.2.4 Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.4.7.2.4.1 Saudi Arabia: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.4.7.2.5 Saudi Arabia: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.2.6 Saudi Arabia: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.3 South Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.3.1 Overview

    11.4.7.3.2 South Africa Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.3.3 South Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.4.7.3.4 South Africa: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.4.7.3.4.1 South Africa: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.4.7.3.5 South Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.3.6 South Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.4 Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.4.1 Overview

    11.4.7.4.2 Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.4.7.4.3 Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.4.7.4.4 Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.4.7.4.4.1 Rest of Middle East and Africa: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.4.7.4.5 Rest of Middle East and Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.4.7.4.6 Rest of Middle East and Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.5 South And Central America Molecular Diagnostics Market Revenue and Forecasts To 2028

    11.5.1 Overview

    11.5.2 South and Central America Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.5.3 South and Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.5.4 South and Central America: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.5.4.1 South and Central America: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.5.5 South and Central America: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.5.6 South and Central America: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.5.7 South and Central America Molecular Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

    11.5.7.1 Argentina Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.5.7.1.1 Overview

    11.5.7.1.2 Argentina Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.5.7.1.3 Argentina: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.5.7.1.4 Argentina: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.5.7.1.4.1 Argentina: Molecular Diagnostics Technology Market, by Type, 2019–2028 (US$ Million)

    11.5.7.1.5 Argentina: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.5.7.1.6 Argentina: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.5.7.2 Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.5.7.2.1 Overview

    11.5.7.2.2 Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    11.5.7.2.3 Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.5.7.2.4 Brazil: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.5.7.2.4.1 Brazil: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.5.7.2.5 Brazil: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    11.5.7.2.6 Brazil: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    11.5.7.3 Rest of South and Central America: Molecular Diagnostics Market– Revenue and Forecast to 2028 (USD Mn)

    11.5.7.3.1 Overview

    11.5.7.3.2 Rest of South and Central America: Molecular Diagnostics Market– Revenue and Forecast to 2028 (USD Mn)

    11.5.7.3.3 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    11.5.7.3.4 Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecasts To 2028, By Technology (US$ Million)

    11.5.7.3.4.1 Rest of South & Central America: Polymerase Chain Reaction (PCR) Market, By Type, 2019–2028 (US$ Million)

    11.5.7.3.5 Rest of South & Central America: Molecular Diagnostics Market, by Product and Services, 2019–2028 (US$ Million)

    11.5.7.3.6 Rest of South and Central America: Molecular Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

    12. Impact Of COVID-19 Pandemic on Molecular Diagnostics Market

    12.1 North America: Impact Assessment of COVID-19 Pandemic

    12.2 Europe: Impact Assessment of COVID-19 Pandemic

    12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

    12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic

    12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

    13. Molecular Diagnostics Market–Industry Landscape

    13.1 Overview

    13.2 Growth Strategies Done by the Companies in the Market (%)

    13.3 Organic Developments

    13.3.1 Overview

    13.4 Inorganic Developments

    13.4.1 Overview

    14. Company Profiles

    14.1 Abbott

    14.1.1 Key Facts

    14.1.2 Business Description

    14.1.3 Products and Services

    14.1.4 Financial Overview

    14.1.5 SWOT Analysis

    14.1.6 Key Developments

    14.2 Agilent Technologies, Inc.

    14.2.1 Key Facts

    14.2.2 Business Description

    14.2.3 Products and Services

    14.2.4 Financial Overview

    14.2.5 SWOT Analysis

    14.2.6 Key Developments

    14.3 THERMO FISHER SCIENTIFIC INC.

    14.3.1 Key Facts

    14.3.2 Business Description

    14.3.3 Products and Services

    14.3.4 Financial Overview

    14.3.5 SWOT Analysis

    14.3.6 Key Developments

    14.4 F. HOFFMANN-LA ROCHE LTD.

    14.4.1 Key Facts

    14.4.2 Business Description

    14.4.3 Products and Services

    14.4.4 Financial Overview

    14.4.5 SWOT Analysis

    14.4.6 Key Developments

    14.5 QIAGEN

    14.5.1 Key Facts

    14.5.2 Business Description

    14.5.3 Products and Services

    14.5.4 Financial Overview

    14.5.5 SWOT Analysis

    14.5.6 Key Developments

    14.6 bioMerieux SA

    14.6.1 Key Facts

    14.6.2 Business Description

    14.6.3 Products and Services

    14.6.4 Financial Overview

    14.6.5 SWOT Analysis

    14.6.6 Key Developments

    14.7 Illumina, Inc.

    14.7.1 Key Facts

    14.7.2 Business Description

    14.7.3 Products and Services

    14.7.4 Financial Overview

    14.7.5 SWOT Analysis

    14.7.6 Key Developments

    14.8 Danaher

    14.8.1 Key Facts

    14.8.2 Business Description

    14.8.3 Products and Services

    14.8.4 Financial Overview

    14.8.5 SWOT Analysis

    14.8.6 Key Developments

    14.9 Siemens Healthineers AG

    14.9.1 Key Facts

    14.9.2 Business Description

    14.9.3 Products and Services

    14.9.4 Financial Overview

    14.9.5 SWOT Analysis

    14.9.6 Key Developments

    14.10 Novartis AG

    14.10.1 Key Facts

    14.10.2 Business Description

    14.10.3 Products and Services

    14.10.4 Financial Overview

    14.10.5 SWOT Analysis

    14.10.6 Key Developments

    14.11 TBG Diagnostics Limited

    14.11.1 Key Facts

    14.11.2 Business Description

    14.11.3 Products and Services

    14.11.4 Financial Overview

    14.11.5 SWOT Analysis

    14.11.6 Key Developments

    15. Appendix

    15.1 About the Insight Partners

    15.2 Glossary of Terms

    LIST OF TABLES

    Table 1. North America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 2. North America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 3. North America: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 4. North America: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 5. North America: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 6. US: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 7. US Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (USD Million)

    Table 8. US: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 9. US: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 10. US: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 11. Canada: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 12. Canada: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 13. Canada: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 14. Canada: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 15. Canada: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 16. Mexico: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 17. Mexico: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 18. Mexico: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 19. Mexico: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 20. Mexico: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 21. Europe: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 22. Europe: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 23. Europe: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 24. Europe: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 25. Europe: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 26. Germany: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 27. Germany: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 28. Germany: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 29. Germany: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 30. Germany: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 31. France: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 32. France: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 33. France: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 34. France: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 35. France: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 36. UK: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 37. UK: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 38. UK: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 39. UK: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 40. UK: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 41. Italy: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 42. Italy: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 43. Italy: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 44. Italy: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 45. Italy: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 46. Spain: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 47. Spain: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 48. Spain: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 49. Spain: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 50. Spain: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 51. Rest of Europe: Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 52. Rest of Europe: Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 53. Rest of Europe: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 54. Rest of Europe: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 55. Rest of Europe: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 56. Asia Pacific Molecular Diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

    Table 57. Asia Pacific Molecular Diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

    Table 58. Asia Pacific : Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

    Table 59. Asia Pacific Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

    Table 60. Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 61. India Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 62. India Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 63. India Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 64. India Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 65. India Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 66. Singapore Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 67. Singapore Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 68. Singapore Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 69. Singapore Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 70. Singapore Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 71. Philippines Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 72. Philippines Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 73. Philippines Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 74. Philippines Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 75. Philippines Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 76. Indonesia Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 77. Indonesia Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 78. Indonesia Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 79. Indonesia Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 80. Indonesia Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 81. Vietnam Molecular diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

    Table 82. Vietnam Molecular diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

    Table 83. Vietnam: Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

    Table 84. Vietnam Molecular diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

    Table 85. Vietnam Molecular diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 86. Thailand Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 87. Thailand Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 88. Thailand Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 89. Thailand Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 90. Thailand Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 91. Malaysia Molecular diagnostics Market, by Disease Area– Revenue and Forecast to 2028 (US$ Million)

    Table 92. Malaysia Molecular diagnostics Market, by Technology– Revenue and Forecast to 2028 (US$ Million)

    Table 93. Malaysia : Polymerase Chain Reaction (PCR) Market, by Type – Revenue and Forecast to 2028 (US$ Million)

    Table 94. Malaysia Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

    Table 95. Malaysia: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 96. Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 97. Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 98. Japan: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 99. Japan: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 100. Japan: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 101. China: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 102. China: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 103. China: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 104. China: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 105. China: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 106. South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 107. South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 108. South Korea: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 109. South Korea: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 110. South Korea: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 111. Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 112. Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 113. Australia: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 114. Australia: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 115. Australia: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 116. Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area – Revenue and Forecast to 2028 (US$ Million)

    Table 117. Rest of Asia Pacific Molecular Diagnostics Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

    Table 118. Rest of Asia Pacific Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 119. Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 120. Rest of Asia Pacific Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 121. Middle East & Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 122. Middle East & Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 123. Middle East & Africa: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 124. Middle East & Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 125. Middle East & Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 126. UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 127. UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 128. UAE: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 129. UAE: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 130. UAE: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 131. Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 132. Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 133. Saudi Arabia: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 134. Saudi Arabia: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 135. Saudi Arabia: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 136. South Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 137. South Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 138. South Africa: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 139. South Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 140. South Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 141. Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 142. Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 143. Rest of Middle East and Africa: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 144. Rest of Middle East and Africa: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 145. Rest of Middle East and Africa: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 146. South and Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 147. South and Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 148. South and Central America: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 149. South and Central America: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 150. South and Central America: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 151. Argentina: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 152. Argentina: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 153. Argentina: Molecular Diagnostics Technology Market, by Type – Revenue and Forecast to 2028 (US$ Million

    Table 154. Argentina: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 155. Argentina: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 156. Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 157. Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 158. Brazil: Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 159. Brazil: Molecular Diagnostics Market, by Product and Services – Revenue and Forecast to 2028 (US$ Million)

    Table 160. Brazil: Molecular Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)

    Table 161. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Disease Area (US$ Million)

    Table 162. Rest of South & Central America: Molecular Diagnostics Market Revenue and Forecasts to 2028, By Technology (US$ Million)

    Table 163. Rest of South & Central America: Polymerase Chain Reaction (PCR) Market, By Type – Revenue and Forecast to 2028 (US$ Million)

    Table 164. Rest of South & Central America: Molecular Diagnostics Market, by Product and Services– Revenue and Forecast to 2028 (US$ Million)

    Table 165. Rest of South and Central America: Molecular Diagnostics Market, by End User– Revenue and Forecast to 2028 (US$ Million)

    Table 166. Organic Developments Done By Companies

    Table 167. Inorganic Developments Done By Companies

    Table 168. Glossary of Terms, Molecular Diagnostics Market

    LIST OF FIGURES

    Figure 1. Molecular Diagnostics Market Segmentation

    Figure 2. Molecular Diagnostics Market, By Region

    Figure 3. Global Molecular Diagnostics Market Overview

    Figure 4. Infectious Disease Segment Held Largest Share of Disease Area Segment in Molecular Diagnostics Market

    Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period

    Figure 6. Molecular Diagnostics Market, by Geography (US$ Million)

    Figure 7. Global Molecular Diagnostics Market- Leading Country Markets (US$ Million)

    Figure 8. Global Molecular Diagnostics Market, Industry Landscape

    Figure 9. North America: PEST Analysis

    Figure 10. Europe: PEST Analysis

    Figure 11. Asia Pacific: PEST Analysis

    Figure 12. Middle East and Africa: PEST Analysis

    Figure 13. South and Central America: PEST Analysis

    Figure 14. Experts Opinion

    Figure 15. Molecular Diagnostics Market: Impact Analysis of Drivers and Restraints

    Figure 16. Global Molecular Diagnostics Market– Revenue Forecast and Analysis – 2021 - 2028

    Figure 17. Global Molecular Diagnostics Market – By Geography Forecast and Analysis – 2020- 2028

    Figure 18. Market Share of Key Players, 2020 (%)

    Figure 19. Molecular Diagnostics Market Revenue Share, by Disease Area (2021 and 2028)

    Figure 20. Oncology: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 21. Infectious Disease: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 22. Genetic Testing: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 23. Cardiac Diseases: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 24. Immune System Disorders: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 25. Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 26. Molecular Diagnostics Market Revenue Share, by Technology (2021 and 2028)

    Figure 27. Polymerase Chain Reaction (PCR): Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 28. RT-PCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 29. qPCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 30. Multiplex PCR: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 31. Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 32. Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 33. DNA Sequencing and Next-Generation Sequencing: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 34. DNA Microarrays: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 35. In-Situ Hybridization: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 36. Others: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 37. Molecular Diagnostics Market, by Product and Services, 2021 & 2028 (%)

    Figure 38. Assays and Kits: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 39. Instruments: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 40. Services and Software: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 41. Molecular Diagnostics Market Share by End User - 2021 & 2028 (%)

    Figure 42. Hospitals and Clinics: Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 43. Diagnostic Laboratories: Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 44. Research and Academic Institutes: Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 45. Others: Molecular Diagnostics Market Revenue and Forecasts To 2028 (US$ Million)

    Figure 46. North America: Molecular Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

    Figure 47. North America Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    Figure 48. North America: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 49. US: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 50. Canada: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 51. Mexico: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 52. Europe: Molecular Diagnostics Market, by Key Country – Revenue (2021) (US$ Million)

    Figure 53. Europe: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    Figure 54. Europe: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 55. Germany: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 56. France: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 57. UK: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 58. Italy: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 59. Spain: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 60. Rest of Europe: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 61. Asia Pacific: Molecular diagnostics Market, by Key Country – Revenue (2021) (USD Million)

    Figure 62. Asia Pacific: Molecular Diagnostics Market Revenue and Forecast to 2028 (US$ Million)

    Figure 63. Asia Pacific: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 64. India: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 65. Singapore: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 66. Philippines: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 67. Indonesia: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 68. Vietnam: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 69. Thailand: Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 70. Malaysia : Molecular diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 71. Japan: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 72. China: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 73. South Korea: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 74. Australia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 75. Rest of Asia Pacific: Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)

    Figure 76. Middle East & Africa Molecular Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)

    Figure 77. Middle East & Africa Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 78. Middle East & Africa: Molecular Diagnostics Market, by Country, 2021 & 2028 (%)

    Figure 79. UAE: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 80. Saudi Arabia: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 81. South Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 82. Rest of Middle East and Africa: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 83. South and Central America Molecular Diagnostics Market Revenue Overview, by Country, 2021 (US$ Million)

    Figure 84. South and Central America Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 85. South and Central America Molecular Diagnostics Market Revenue and Forecasts to 2028, By Country (%)

    Figure 86. Argentina Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 87. Brazil: Molecular Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)

    Figure 88. Rest of South and Central America: Molecular Diagnostics Market– Revenue and Forecast to 2028 (USD Mn)

    Figure 89. Impact of COVID-19 Pandemic in North American Country Markets

    Figure 90. Impact of COVID-19 Pandemic in European Country Markets

    Figure 91. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

    Figure 92. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets

    Figure 93. Impact of COVID-19 Pandemic on Molecular Diagnostic Market in South and Central America

    Figure 94. Growth Strategies Done by the Companies in the Market (%)

    The List of Companies - Molecular Diagnostics Market

    1. Abbott
    2. Agilent Technologies, Inc.
    3. Thermo Fisher Scientific Inc.
    4. F. Hoffmann-La Roche Ltd.
    5. TBG Diagnostics Limited
    6. QIAGEN
    7. bioMérieux SA
    8. Siemens Healthineers AG
    9. Illumina, Inc.
    10. Danaher
    11. Novartis AG
    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the molecular diagnostics market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in the global molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
    TIPRE00003124
    Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

    Get the Latest COVID-19 Analysis on this market



    Frequently Asked Questions

    Molecular diagnostics is considered among the most reliable method to identify and analyze a microorganism. Molecular diagnostics helps in better testing, quick identification of the organism’s strain and drug susceptibility. Technological advancements, like a polymerase chain reaction (PCR), and others, the rising application of molecular diagnostics is expected to drive the market during the forecast period.
    The global molecular diagnostics market is being driven by factors such increase in demand for point-of-care and developments by market players and increasing prevalence of associated diseases in market developments, development potential in emerging countries are likely to offer significant opportunities for the growth of the global molecular diagnostics market.
    The limitations associated the molecular testing is the significant factor that will hinder the molecular diagnostics market growth.
    The key players in the global molecular diagnostics are Abbott, Agilent Technologies, Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., TBG Diagnostics Limited, QIAGEN, bioMérieux SA, Siemens Healthineers AG, Illumina, Inc., Danaher, Novartis AG are among others.
    The market players in the global market in constantly involved in the product development and innovations as part of their business strategies such as product launch, mergers and acquisitions, partnership and others. For instance, September 2021 Novartis acquired Arctos Medical, adding a pre-clinical optogenetics-based AAV gene therapy program and Arctos’ proprietary technology to its ophthalmology portfolio. The acquisition underscores the Novartis commitment to finding treatments for patients with vision loss and the potential of optogenetics as the basis of successful therapeutics.
    The Asia Pacific is expected to be the fastest-growing region in the molecular diagnostics market. The growth of the market in this region is primarily due to the rising application of molecular diagnostics and the active participation of the players in market developments

    Pricing
    • $3000
    • $4550
    • $6550
    • $8550

        GET FREE SAMPLE PDF

    Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

        Inquire for Discount   Speak to Analyst